SMA drug Zolgensma finally makes Alberta's Rare Diseases Drug Coverage Program
Coverage for Zolgensma, a gene therapy used to treat spinal muscular atrophy, is now permanently available in Alberta.
The therapy was added to the province's Rare Diseases Drug Coverage Program after the pan-Canadian Pharmaceutical Alliance (pCPA) reached a long-term pricing agreement with manufacturer Novartis Pharmaceuticals Canada Inc. in October.
Alberta Health Minister Jason Copping said in a statement the government was "extremely pleased" at the development and Alberta's new ability to offer the treatment on a more secure basis.
The province had been providing access to the drug on its own pending a national drug review, approval and the price negotiations with Novartis.
Zolgensma, a one-time treatment with a price tag of $2.91 million, is administered by intravenous infusion to replace a missing or faulty gene that results in spinal muscular atrophy (SMA). The rare disorder can cause a loss of muscle function and is seen in about one in 10,000 Canadian babies each year, according to the National Organization for Rare Disorders.
Zolgensma is supposed to stop the disease's progression and restore protein production of the missing or defective SMN1 gene. It must be administered when a patient is a toddler.
Several Alberta families led the push to have it approved and covered in Alberta and Canada.
Spinraza, a spinal injection given three times a year that can be used as a treatment for SMA, is also covered under the Alberta Drug Benefit List.
CTVNews.ca Top Stories
DEVELOPING Hurricane Milton strengthens into a Category 5 storm. Florida orders evacuations
Hurricane Milton strengthens into a Category 5 storm off Mexico and threatens Florida, forecasters say.
'Selfish billionaire': Chip Wilson's mansion vandalized after political sign erected outside
Days after a political sign was erected outside Chip Wilson's Vancouver mansion, the waterfront property has been vandalized with graffiti.
Cissy Houston, Whitney Houston's mother and a Grammy-winning singer, dies at 91
Cissy Houston, the mother of the late Whitney Houston and a two-time Grammy winner who performed alongside superstar musicians like Elvis Presley, and Aretha Franklin, has died. She was 91.
Two people injured in apparent road rage incident, shooting in Toronto
Two people are in hospital after they were chased and shot at in what appears to be an act of road rage before eventually flipping their car while trying to escape, police say.
Canadian soldier wins compensation for cancer linked to burn pits after Veterans Affairs denied claim
A Canadian soldier who was exposed to toxic chemicals from burn pits while serving in Afghanistan has been awarded full medical compensation for testicular cancer after Veterans Affairs initially denied his claim.
Sammy Basso, longest living survivor of rare rapid-aging disease progeria, dies at 28
Sammy Basso, who was the longest living survivor of the rare genetic disease progeria, has died at the age of 28, the Italian Progeria Association said on Sunday.
A Canadian woman was recently diagnosed with scurvy. Here are the factors tied to the disease
Scurvy is not just an archaic diagnosis of 18th-century seafarers and doctors should watch for possible cases, according to researchers following a recent case.
Canadian leaders, demonstrators hold events on anniversary of Oct. 7 attack
Ceremonies, events and protests are being held across Canada today to mark the anniversary of a Hamas attack on Israel that triggered the ongoing war in Gaza.
Who will end the debate? Political gridlock continues in the House of Commons
Federal political parties appear to be locked in a game of chicken over a debate that has stalled almost all business in the House of Commons.